These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11064354)

  • 1. Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo.
    Okamoto M; Hiura K; Ohe G; Ohba Y; Terai K; Oshikawa T; Furuichi S; Nishikawa H; Moriyama K; Yoshida H; Sato M
    Cancer; 2000 Nov; 89(9):1966-75. PubMed ID: 11064354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts.
    Tada T; Jimi E; Okamoto M; Ozeki S; Okabe K
    Int J Cancer; 2005 Aug; 116(2):253-62. PubMed ID: 15800904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral squamous cell carcinomas stimulate osteoclast differentiation.
    Deyama Y; Tei K; Yoshimura Y; Izumiyama Y; Takeyama S; Hatta M; Totsuka Y; Suzuki K
    Oncol Rep; 2008 Sep; 20(3):663-8. PubMed ID: 18695921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells.
    Kayamori K; Sakamoto K; Nakashima T; Takayanagi H; Morita K; Omura K; Nguyen ST; Miki Y; Iimura T; Himeno A; Akashi T; Yamada-Okabe H; Ogata E; Yamaguchi A
    Am J Pathol; 2010 Feb; 176(2):968-80. PubMed ID: 20035059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
    Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
    Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J
    Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction.
    Oue E; Lee JW; Sakamoto K; Iimura T; Aoki K; Kayamori K; Michi Y; Yamashiro M; Harada K; Amagasa T; Yamaguchi A
    Biochem Biophys Res Commun; 2012 Aug; 424(3):456-61. PubMed ID: 22771802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral squamous cell carcinoma cells modulate osteoclast function by RANKL-dependent and -independent mechanisms.
    Tada T; Shin M; Fukushima H; Okabe K; Ozeki S; Okamoto M; Jimi E
    Cancer Lett; 2009 Feb; 274(1):126-31. PubMed ID: 18930344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone.
    Ohsaki Y; Takahashi S; Scarcez T; Demulder A; Nishihara T; Williams R; Roodman GD
    Endocrinology; 1992 Nov; 131(5):2229-34. PubMed ID: 1425421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption.
    Hwang YS; Lee SK; Park KK; Chung WY
    Oral Oncol; 2012 Jan; 48(1):40-8. PubMed ID: 21925926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Hou Y; Long W; Ye S; Wang Z
    Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a murine model of bone invasion by oral squamous cell carcinoma.
    Nomura T; Shibahara T; Katakura A; Matsubara S; Takano N
    Oral Oncol; 2007 Mar; 43(3):257-62. PubMed ID: 16920384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines.
    Kawamata H; Nakashiro K; Uchida D; Harada K; Yoshida H; Sato M
    Int J Cancer; 1997 Jan; 70(1):120-7. PubMed ID: 8985100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human breast-cancer cells stimulate the fusion, migration and resorptive activity of osteoclasts in bone explants.
    Tumber A; Morgan HM; Meikle MC; Hill PA
    Int J Cancer; 2001 Mar; 91(5):665-72. PubMed ID: 11267975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer.
    Sato K; Lee JW; Sakamoto K; Iimura T; Kayamori K; Yasuda H; Shindoh M; Ito M; Omura K; Yamaguchi A
    Am J Pathol; 2013 May; 182(5):1890-9. PubMed ID: 23499553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma.
    Jimi E; Furuta H; Matsuo K; Tominaga K; Takahashi T; Nakanishi O
    Oral Dis; 2011 Jul; 17(5):462-8. PubMed ID: 21496184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the fibrous stroma in bone invasion by human gingival squamous cell carcinomas.
    Ishikuro M; Sakamoto K; Kayamori K; Akashi T; Kanda H; Izumo T; Yamaguchi A
    Bone; 2008 Sep; 43(3):621-7. PubMed ID: 18585993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
    Quan J; Morrison NA; Johnson NW; Gao J
    J Cell Biochem; 2014 Oct; 115(10):1787-98. PubMed ID: 24905457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.